The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.